α1-Antitrypsin deficiency

Thorax

Volumn 59, Issue 2, 2004, Pages 92-93

  Stoller, J K ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DNA MODIFICATION; DRUG EFFICACY; EDITORIAL; EMPHYSEMA; EPIDEMIOLOGICAL DATA; GENETIC ASSOCIATION; HISTORY OF MEDICINE; HUMAN; IMAGING SYSTEM; LUNG DISEASE; MOLECULAR DYNAMICS; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME; MIDDLE AGED;

ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; MIDDLE AGED;

EID: 1242351729     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.2003.017517     Document Type: Editorial

References (18)

1. O'Brien ML, Buist NRM, Murphy WH. Neonatal screening for alpha 1-antitrypsin deficiency. J Pediatr 1978;92:1006-10.
2. Sveger T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21.
3. Stoller JK, Smith P, Yang P, et al. Physical and social impact of alpha 1-ontitrypsin deficiency: results of a survey. Cleve Clin J Med 1994;61:461-7.
4. Silverman EK, Miletich JP, Pierce JA, et al. Alpha 1-antitrypsin deficiency: high prevalence in the St Louis area determined by direct population screening. Am Rev Respir Dis 1989;140:961-6.
5. Needham M, Stockley RA. Clinical manifestations and natural history of alpha 1-antitrypsin deficiency. Thorax 2004;59 (in press).
6. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
7. Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62.
8. Stoller JK, Rouhani F, Brantly M, et al. Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin. Chest 2002;122:66-74.
9. 1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997;10:2260-3.
10. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 1998;158:49-59.
11. Wencker M, Fuhrmann B, Banik N, et al. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001;119:737-44.
12. Sveger T, Piitulainen E, Arborelius M Jr. Lung function in adolescents with alpha 1-antitrypsin deficiency. Acta Paediatr 1994;83:1170-3.
13. Wall M, Moe E, Eisenberg J, et al. Long-term follow-up of a cohort of children with alpha 1-antitrypsin deficiency. J Pediatr 1990;116:248-51.
14. Dirksen A, Dijkman JH, Madsen F, et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160(5 Pt1):1468-72.
15. Minai OA, Stoller JK. Therapy for alpha 1-antitrypsin deficiency: pharmacology and clinical recommendations. BioDrugs 2000;13:135-47.
16. 1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J 2001;8:81-8.
17. Stoller JK. Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial? Thorax 1998;53:1007-9.
18. Sandhaus RA. New and emerging therapies for AAT deficiency. Thorax 2004 (in press).